Galapagos | Salg



Sales Endring Dato
argenx SE USD 671.52M 129.45M 2024-12
AstraZeneca USD 13.59B 1.3B 2025-03
Biogen USD 2.43B 24.7M 2025-03
Genmab DKK 64.41B 58.87B 2024-12
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
GRIFOLS EUR 1.94B 150M 2024-12
Hikma Pharmaceutical USD 1.57B 121M 2024-06
Incyte USD 1.05B 128.7M 2025-03
Merck EUR 5.42B 152M 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.15B 330M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.9B 660M 2025-03
UCB EUR 2.79B 127M 2024-06
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Galapagos Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.